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expired were those who developed cerebritis, meningitis or
brain abscess.
Conclusion: Mucormycosis is a rare but usually fatal fungal
infection. High index of suspicion, early diagnosis, and
combination treatment with antifungal agents and surgical
debridement may improve the prognosis of this serious
infection. Resistance to amphotericin B is increasing in
mucoral agents. Mocurmycosis has a good response to
posaconazole.
PP-063 Etiological spectrum of fungal infections in
immunodepressed patients from Timis County,
Romania
I. Marincu1 *, L. Negrut¸iu1, I. Iacobiciu1, M. Mares¸2,
A. Neghina1, L. Tirnea1, C. Calma1, R. Neghina1.
1Victor Babes University of Medicine and Pharmacy from
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Background: The morbidity and mortality rates are
signiﬁcantly increased in immunodepressed patients as a
result of severe fungal infections. The present study aimed
to conduct a retrospective investigation of the etiology of
fungal infections in a group of immunodepressed patients.
Methods: The authors have retrospectively analyzed
the hospital records of 79 immunodepressed patients
(44 males, 35 females) admitted at the Department
of Infectious Diseases from Timisoara. The positive
diagnosis was established based on physical examination
(fever, weight loss, white depots on tongue, headache,
anorexia, asthenia) and laboratory data (leukocyte count,
erythrocyte sedimentation rate, C reactive protein, titre
of antistreptolysin O antibodies, electrophoresis, blood
culture, sputum culture, ELISA, Western blot, glossal
exudate and CHROM-AGAR or Sabouraud medium culture).
The identiﬁcation has been made by API Candida system,
ATB Fungus 2 system testing for antifungal sensibility and
direct microscopy examination of fungal specimens. The
data obtained was statistically processed with EpiInfo 5
program.
Results: The study group was distributed as follows:
16 patients had diabetes mellitus, 24 had chronic hepatitis,
12 had liver cirrhosis, 12 had hematological malignancies,
6 had pulmonary tuberculosis, 5 had breast cancer and 4
had pulmonary cancer. Fungal infections were diagnosed in
65 patients (82.27%): 50 patients (76.92%) presented glossal
candidiasis, 12 (18.46%) had oropharingeal candidiasis, and
3 (4.61%) had esophageal candidiasis. There have been
isolated 40 strains of Candida albicans and 25 strains of
Candida non-albicans (p = 0.03) among which 10 strains of
Candida glabrata, 9 strains of Candida keﬁr and 6 strains
of Candida parapsilosis. Out of the 40 strains of Candida
albicans, 26 were resistant to ﬂuconazole (p = 0.04) but all
were sensitive to itraconazole.
Conclusion: The knowledge of the etiological spectrum of
fungal infections in immunocompromised patients allows
the proper implementation of the antifungal treatment and
prophylaxis measures thus leading to satisfying results.
PP-064 Cutaneous zygomycosis of the scalp:
a case report and review of the literature
A. Alsaedy1 *, S. Baharoon1. 1King Abdulaziz Medical City,
Saudi Arabia
Background: The incidence of the life-threatening invasive
fungal infection, Zygomycosis, has been increasing over
the past two decades. Cutaneous Zygomycosis represents
the third most common type, following Rhinocerebral
and Pulmonary forms. It can be superﬁcial, invasive or
disseminated. Primary and isolated Scalp involvement is
very rare.
Method: We report a case of scalp Zygomycosis in a diabetic
patient presented with large eschar. He was treated by
surgical excision, skin graft and antifungal therapy using
Amphotericin B lipid complex for one month followed by
Posaconazole for three months.
Results: He was successively cured with no evidence of
recurrence for one year.
Conclusion: Cutaneous Zygomycosis requires high index of
clinical suspicion for timely diagnosis through early skin
biopsy for histopathology and culture particularly if there
is a skin necrosis. Treatment consists of combination of
prompt surgical intervention and antifungal therapy.
PP-065 Establishment and analysis of murine model of
invasive pulmonary aspergillosis
C.-R. Zhang1 *, Y.-L. Xin1, Y.-Y. Niu1, M. Li1, J.-C. Lin1.
1Huang Pu Hospital of the First Afﬁliated Hospital, Sun
Yat-sen University, Guangzhou 510700, China
Aim: To establish a murine model of invasive pulmonary
aspergillosis and to analyze its reserch value.
Methods: Mice were immunosuppressed with cyclosphos-
phamide by intraperitoneal injections and in the process
routine blood test were monitored. Invasive pulmonary
aspergillosis was induced by inoculation of Aspergillus
fumigatus spore suspension with self-made tracheal
intubation. Mice were sacriﬁced on day 1, 3, 5, 7 after
inoculation and their lung tissues were was cultured and
histopathologically analyzed.
Results: Mice shows a loss of weight and depression after
a series of different dose of cyclosphosphamide injection.
Routine blood test shows a signiﬁcant decrease of white
blood cells. Nutrogranulocytes and lymphocytes can’t be
distinguished. By observing pathological slices, we can
see lung tissue lesion aggrates gradually after inoculation.
Haemorrhage and cellulose exsudation is obviously seen;
sporus aggregat and germinate. As a result, alveoli are
destroyed diffusely and a large area of lung edema
happened.
Conclusions: A murine model of invasive pulmonary
aspergillosis is succes sfully established, which will de a
reference of further studies of aspergillosis pathogenesis
and pathophysiology, in addition to antifungal agent
pharmacodynamics.
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Mucormycosis invasive fungal infection affecting any
organ. Over 50% of cases are rhinocerebral involvement
requiring emergent, aggressive, disﬁguring facial surgery.
Mucormycosis affects immunocompromised patients or
those with metabolic abnormalities.
51yo woman presented with lethargy, decreased PO intake
for 5 days. PMH: DM, HTN (both non-compliant), CVA, PE,
DVT, IVC ﬁlter.
Patient underwent procedure for dental abscess in right
maxilla 5 days before admission, was on amoxicillin, denied
recent fevers, chills. She hasn’t been taking insulin for
unknown time.
On examination: right-sided facial swelling, numbness, right
eye closed with surrounding erythema, proptosis, diplopia,
decreased visual acuity. Nasal mucosa didn’t reveal black
turbinates.
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On admission: blood sugar 693, ketones 40, anion gap
27 and WBC 14.6. T max 99.2F. MRI brain/orbits, CT
sinuses/orbits showed right orbital cellulitis/right maxillary
sinusitis without CNS extension.
Aggressive therapy for DKA was initiated, empiric cefepime,
metronidazole, vancomycin and amphotericin B were begun.
ENT urgently took patient to OR for possible invasive
rhinocerebral fungal disease. Maxillary sinus pathology
conﬁrmed mucor. Patient was transferred to a NYC hospital.
Sinus surgery included resection of the inferior, middle
turbinates, medial wall and the roof of maxillary sinus. Right
orbital exenteration was recommended, but refused by the
patient, who was deemed by psychiatry as competent and
understanding potential complications. Before discharge
amphotericin B was switched to posaconazole.
Patient remained on posaconazole as “salvage therapy” for
over one year. There has been no recurrence of diplopia
or facial numbness. Repeated MRI/CT sinuses showed no
further involvement and remained stable.
Mucormycosis is a serious invasive fungal infection, affecting
people with poorly controlled diabetes. Rhinocerebral
mucormycosis could be rapidly fatal disease with delayed
diagnosis, and surgery remains the mainstay treatment.
Amphotericin B has been the antifungal drug of choice.
Posaconazole, a novel medicine, has shown promising results
as a salvage therapy.
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PP-067 Aciclovir in inﬂuenza, a novel experience
M. Owlia1 *, S. Owlia2, M. Shariﬁ1. 1Shahid Sadoughi
University of Medical Sciences, 2Shahid Sadoughi school for
exceptional talents, Iran
Background: Inﬂuenza (ﬂu), is an infectious disease caused
by RNA viruses of the family Orthomyxoviridea. This is
one of the most contagious and morbid viral condition
worldwide. It has a big social and economical burden. Flu
could be fatal in some instances. The two classes of antiviral
drugs used against inﬂuenza are neuraminidase inhibitors
and M2 protein inhibitors. No study we found that worked
on aciclovir in ﬂu.
Methods: We prescribed aciclovir 400mg/6 hrs orally along
with acetaminophen 500mg/6 hrs for 5 days for 15 cases of
clinically diagnosed with ﬂu with constellation of high grade
fever, myalgia, headache of less than three day duration in
epidemic period of ﬂu in 3 sequential years in Yazd, central
Iran from 2009 2011.
Results: Mean range of ages was 32±6 years. Six patients
had history of recent ﬂu in their family. 12 patients
had rapid clinical improvement within 48 hrs that was
expressed dramatic by them. Remaining three, improved
rather slowly within ﬁve days. Temperature, myalgia and
headache dropped to normal condition rapidly. All of them
returned to work after three days of treatment.
Conclusion: Unlike previous data, It seems that aciclovir
could have a powerful theraputic effect of non-herpes
related infections notably ﬂu. Further RCTs should
potentiate results of this trial.
PP-068 Pandemic H1N1 inﬂuence in pregnant women:
clinical features and one year follow up
H.F. Xiong1 *, Y.-Q. Jiao1, J.-Y. Liu1, B.-S. Li1, G.W. Yu2.
1ICU, Beijing Ditan Hospital, Capital Medical University,
2Beijing Ditan Hospital, Capital Medical University, China
Objective: To describe the clinical features and one year
follow up condition of pandemic H1N1 inﬂuence in pregnant
women.
Methods: The clinical features and supplemental data were
analyzed. One year follow up was performed from Dec 2010
to Jan 2011.
Results: From May 15 to Jan 10, 2010, 32 conﬁrmed cases
of pandemic H1N1 in pregnant women were admitted to
hospital. They ranged in age from 22 33 years (media 26.1).
13 (40.6%) women were in the ﬁrst or second trimester of
pregnancy and 19 (59.4%) were in the third trimester. The
most common symptoms were fever in 93.8%, coughing
in 46.9%, sore throat in 40.6%, shortness of breath
in 31.3%, hemoptysis in 12.5%. Six patients who had
developed pneumonia and subsequent acute respiratory
distress syndrome requiring mechanical ventilation, three
patients requiring Extracorporeal Membrane Oxygenation
(ECMO). Emergency caesarean delivery was preformed in
four patients for premature rupture of membranes (in three
cases) and dead fetus in uterus (in one case) and one patient
delivered a dead fetus herself in the hospital. As to one year
follow up condition: all patients and infants were healthy
except one give induced abortion in the twenty-six patients.
Two patients (all in critical group) have abnormal lung
function, mainly a slight decrease in ventilation function
and small airway obstruction. Cardiac structure and function
are normal in all patients. Three patients have abnormal
in CT scan, mainly focal chronic inﬂammation and ﬁbrosis
(3 cases) and bronchiectasis (1 case).
Conclusion: Pregnant women might be at increased risk
for complications from pandemic H1N1 virus infection. One
year follow up condition show some patients may suffer
from lingering effects such as pulmonary ﬁbrosis.
PP-069 Viral aspects of allergy
A. Prasad1 *. 1Inﬂuenza Foundation of India, India
Viruses as Allergens: Incidence of allergic disorders and
bronchial asthma is on increase. Till now we mostly
understand that the plant allergens, house dustmites,
chemicals, etc. causes allergy. But while looking for speciﬁc
IgE for inﬂuenza virus, an interesting observation was found,
that in certain group where repeat viral infections in young
children were observed, the incidence of allergic bronchitis
and asthma was higher or, at least they were more prone
to become the future allergic or, asthmatic patients. These
patients have much higher tendency to be the future case
of chronic respiratory diseases.
The further investigations revealed that respiratory viruses
(inﬂuenza A) produce a similar chemical pathway that leads
to a situation of becoming allergic. This observation is
based on clinical and supplemented by the epidemiological
& immunological studies. This was further sublimated by
animal experiments carried out on the tracheal muscles.
I will be giving some of these details in my talk today.
The animal experiments carried out on the experimentally
infected G. pigs showed strong evidence for producing
bronchial constriction on the tracheal muscles. Inﬂuenza
speciﬁc IgE was seen much higher in case inﬂuenza infected
cases.
Conclusion & Suggestion: Based on Experimental results:
Inﬂuenza A virus experimentally in I/D test (G. Pig)
produces type 3 allergic reaction.
Signiﬁcant change in airway smooth muscle response to
bronchoactive agents during inﬂuenza A viral infection.
Increase in inﬂuenza speciﬁc IgE in Inﬂuenza A viral
infections.
Considering inﬂuenza virus, an Allergy role in the chemical
pathways or, as a pre-indicative stage for this group as
a prone group, a preventive therapy of Inﬂuenza Vaccine
will protect, and avoid unnecessary complications and
hospitalization.
